Evaluation of protein fractions in the serum as potential determinants of risk of the recurrent miscarriages
Abstract
Background: According to the World Health Organization, recurrent miscarriage is defined as the loss of 3 or
more consecutive early pregnancies, affecting 0.5% to 3% of pregnant women. According to clinical practice,
it is recommended to perform a diagnostic investigation after two consecutive miscarriages in order to
identify the reason for miscarriages. Despite numerous investigations, around 40–60% of recurrent pregnancy
losses is still idiopathic. In the conducted research, the utility of the determination of serum protein
fractions in the diagnosis of recurrent miscarriage was evaluated.
Material and methods: The study group consisted of 20 women (aged 36.12 ± 3.53) with recurrent miscarriage
of undetermined aetiology. The control group comprised 20 non-pregnant women (aged 35.7 ± 3.28) who
had given birth to healthy children at least twice. Blood serum collected by venipuncture was examined.
Serum protein fractions were separated by electrophoresis in the SDS PAGE buffer system using a Mini
PROTEAN 3 cell device. BioRad SDS PAGE Molecular Weight Standards covering a mass range of 6.5–200
kDa were used as a reference.
Results: Electrophoretic separation revealed 71 protein fractions of 10 to 240 kDa. It was observed that protein
fractions with molecular weights of 27, 36, 53 and 172 kDa were present more frequently in serum from
women in the control group. Protein fractions of 28, 132 and 188 kDa predominated among patients in the
experimental group. This research has demonstrated that the number of 53 and 172 kDa protein fractions
decreased with the number of miscarriages.
Conclusions: It is suggested that individual protein fractions may increase the risk of a miscarriage.
Keywords: recurrent miscarriageprotein fractionsabortionpregnancyelectrophoresis
References
- Diejomaoh MFE. Recurrent spontaneous miscarriage is still a challenging diagnostic and therapeutic quagmire. Med Princ Pract. 2015; 24 Suppl 1: 38–55.
- Rekomendacje Polskiego Towarzystwa Ginekologicznego w zakresie wybranych patologii wczesnej ciąży oraz postępowania w ciąży po zapłodnieniu in vitro. Prz Menopauz, 2004; 6. ; 8: 8–12.
- Bręborowicz GH, Urban J, Skrzypczak J, et al. Położnictwo i ginekologia. Red. Wydawnictwo Lekarskie PZWL, Warszawa 2014; 1: 85-91. : 160–162.
- Lewicka M, Sulima M, Pyć M, et al. Charakterystyka poronień i prawa przysługujące kobiecie po stracie ciąży. Annales Academiae Medicae Stetinensis – Roczniki Pomorskiej Akademii Medycznej w Szczecinie, 2013; 59. ; 1: 123–129.
- Malinowski A, Radwan M. Diagnostyka immunologiczna w poronieniach nawykowych: algorytm postępowania diagnostyczno-leczniczego z wykorzystaniem wyników badań własnych, Perinatol Neonatol Ginekol. 2011; 4. ; 4: 27–36.
- Pereza N, Ostojić S, Smirčić A, et al. The -2549 insertion/deletion polymorphism in the promoter region of the VEGFA gene in couples with idiopathic recurrent spontaneous abortion. J Assist Reprod Genet. 2015; 32(12): 1789–1794.
- Nagirnaja L, Palta P, Kasak L, et al. Structural genomic variation as risk factor for idiopathic recurrent miscarriage. Hum Mutat. 2014; 35(8): 972–982.
- Kim MS, Gu BH, Song S, et al. ITI-H4, as a biomarker in the serum of recurrent pregnancy loss (RPL) patients. Mol Biosyst. 2011; 7(5): 1430–1440.